Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Taxes (2020 - 2023)

Apyx Medical's Change in Taxes history spans 4 years, with the latest figure at -$7.8 million for Q3 2023.

  • For Q3 2023, Change in Taxes fell 7891.75% year-over-year to -$7.8 million; the TTM value through Jun 2024 reached -$7.8 million, down 7147.27%, while the annual FY2023 figure was -$7.5 million, 7678.35% down from the prior year.
  • Change in Taxes reached -$7.8 million in Q3 2023 per APYX's latest filing, down from $207000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $4.6 million in Q1 2020 to a low of -$7.8 million in Q3 2023.
  • Average Change in Taxes over 4 years is -$53250.0, with a median of $311500.0 recorded in 2020.
  • Peak YoY movement for Change in Taxes: crashed 102.88% in 2021, then tumbled 7891.75% in 2023.
  • A 4-year view of Change in Taxes shows it stood at $416000.0 in 2020, then plummeted by 102.88% to -$12000.0 in 2021, then plummeted by 708.33% to -$97000.0 in 2022, then crashed by 7891.75% to -$7.8 million in 2023.
  • Per Business Quant, the three most recent readings for APYX's Change in Taxes are -$7.8 million (Q3 2023), $207000.0 (Q1 2023), and -$97000.0 (Q3 2022).